|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn893486934 |
| 003 |
OCoLC |
| 005 |
20231120111815.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
141021s1975 nyua ob 101 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d UAB
|d OCLCA
|d OCLCQ
|d UKAHL
|d LUN
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781483269719
|q (electronic bk.)
|
| 020 |
|
|
|a 148326971X
|q (electronic bk.)
|
| 020 |
|
|
|z 012560565X
|
| 020 |
|
|
|z 9780125605656
|
| 035 |
|
|
|a (OCoLC)893486934
|
| 050 |
|
4 |
|a QR360
|
| 060 |
|
4 |
|a W3
|b PE58 v.9 1974
|
| 060 |
|
4 |
|a WC 500
|b G982 1974a
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.9/1
|2 23
|
| 084 |
|
|
|a 44.75
|2 bcl
|
| 245 |
0 |
0 |
|a Antiviral mechanisms /
|c edited by Morris Pollard.
|
| 264 |
|
1 |
|a New York :
|b Academic Press,
|c 1975.
|
| 300 |
|
|
|a 1 online resource (xxxi, 343 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Perspectives in virology ;
|v 9
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 611 |
2 |
0 |
|a Gustav Stern Symposium.
|t Perspectives in virology
|v 9.
|
| 650 |
|
0 |
|a Virus diseases
|x Immunological aspects
|v Congresses.
|
| 650 |
|
0 |
|a Interferon
|v Congresses.
|
| 650 |
|
0 |
|a Antiviral agents.
|
| 650 |
|
2 |
|a Antiviral Agents
|0 (DNLM)D000998
|
| 650 |
|
2 |
|a Virus Diseases
|x immunology
|0 (DNLM)D014777Q000276
|
| 650 |
|
6 |
|a Antiviraux.
|0 (CaQQLa)201-0025468
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Antiviral agents
|2 fast
|0 (OCoLC)fst00810869
|
| 650 |
|
7 |
|a Interferon
|2 fast
|0 (OCoLC)fst00976239
|
| 650 |
|
7 |
|a Virus diseases
|x Immunological aspects
|2 fast
|0 (OCoLC)fst01167749
|
| 655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
| 655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
| 655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
| 700 |
1 |
|
|a Pollard, Morris,
|e author.
|
| 776 |
0 |
8 |
|i Print version:
|t Antiviral mechanisms
|z 012560565X
|w (DLC) 75317441
|w (OCoLC)1529982
|
| 830 |
|
0 |
|a Persepectives in virology.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780125605656
|z Texto completo
|
